Sempulse® announces U.S. FDA 510(k) Clearance and the Commercial Launch of the Halo™ Vital Signs Monitoring System May 21, 2024 Kurt Stump General No comments yet San Marcos, TX, May 16, 2024 – Sempulse today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of the Sempulse Halo Vital […] Read more
Recent Comments